FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048404771> ?p ?o ?g. }

• W3048404771 endingPage "105115" @default.
• W3048404771 startingPage "105115" @default.
• W3048404771 abstract "Ipsilateral nonstenotic carotid disease is increasingly recognized as an etiology of ischemic stroke, however tailored treatment strategies are lacking. We aimed to examine clinical characteristics and treatment effects in patients with minor ischemic stroke associated with ipsilateral nonstenotic carotid disease in the Platelet Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trial.We performed an exploratory analysis of the interaction of the treatment effects of aspirin plus clopidogrel versus aspirin monotherapy, stratified by presence of ipsilateral nonstenotic carotid disease in patients with minor ischemic stroke in the POINT trial.For this exploratory analysis, 167 patients presenting with ischemic stroke and ipsilateral nonstenotic carotid disease, defined as 1%-49% carotid stenosis ipsilateral to the corresponding territory of ischemic stroke, and 833 patients no carotid disease were included. Compared to patients with no carotid disease, patients with ipsilateral nonstenotic carotid disease were older (68.5 ± 11.3 years versus 61.3 ± 12.8 years; P < 0.001), and had a higher prevalence of hypertension (76.6% versus 59.2%, P < 0.001), ischemic heart disease (13.8% versus 5.4%, P < 0.001), and tobacco use (past: 34.1% versus 25.2%, P = 0.005; present: 27.5% versus 22.8%, P = 0.005). 5.4% of patients with ipsilateral nonstenotic carotid disease had recurrent ischemic stroke within 14 days. Patients receiving dual antiplatelet therapy had a numerical reduction in recurrent ischemic stroke compared to patients receiving aspirin monotherapy, however the exploratory analysis was underpowered to detect a statistically significant difference in treatment effect (HR 0.50, 95% CI 0.18-1.40, P = 0.19).Patients with minor ischemic stroke and ipsilateral nonstenotic carotid disease had a high risk of early stroke recurrence in the POINT trial. Dual antiplatelet therapy provided a non-statistically significant reduction in recurrent ischemic stroke with no difference in safety outcomes compared to aspirin monotherapy. Further study is needed to determine if early and short duration dual antiplatelet therapy is beneficial for all patients with ipsilateral nonstenotic carotid disease." @default.
• W3048404771 created "2020-08-18" @default.
• W3048404771 creator A5004327096 @default.
• W3048404771 creator A5004731367 @default.
• W3048404771 creator A5029096082 @default.
• W3048404771 creator A5070691919 @default.
• W3048404771 date "2020-11-01" @default.
• W3048404771 modified "2023-09-26" @default.
• W3048404771 title "Ipsilateral Nonstenotic Carotid Disease in Minor Ischemic Stroke: an Exploratory Analysis of The POINT Randomized Clinical Trial" @default.
• W3048404771 cites W1968737649 @default.
• W3048404771 cites W1996490798 @default.
• W3048404771 cites W2000255615 @default.
• W3048404771 cites W2081615170 @default.
• W3048404771 cites W2100092655 @default.
• W3048404771 cites W2116427214 @default.
• W3048404771 cites W2123634131 @default.
• W3048404771 cites W2138595885 @default.
• W3048404771 cites W2148919757 @default.
• W3048404771 cites W2153274104 @default.
• W3048404771 cites W2361921955 @default.
• W3048404771 cites W2461718870 @default.
• W3048404771 cites W2463533415 @default.
• W3048404771 cites W2585204455 @default.
• W3048404771 cites W2591456311 @default.
• W3048404771 cites W2740481260 @default.
• W3048404771 cites W2758668654 @default.
• W3048404771 cites W2782176193 @default.
• W3048404771 cites W2804570339 @default.
• W3048404771 cites W2903357985 @default.
• W3048404771 cites W2911614100 @default.
• W3048404771 cites W2927941727 @default.
• W3048404771 cites W2944133085 @default.
• W3048404771 cites W2968156277 @default.
• W3048404771 cites W2979817571 @default.
• W3048404771 cites W2982303713 @default.
• W3048404771 cites W2989834949 @default.
• W3048404771 cites W2994900396 @default.
• W3048404771 cites W2995634622 @default.
• W3048404771 cites W2997156187 @default.
• W3048404771 cites W3009169605 @default.
• W3048404771 cites W3023860430 @default.
• W3048404771 doi "https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105115" @default.
• W3048404771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33066893" @default.
• W3048404771 hasPublicationYear "2020" @default.
• W3048404771 type Work @default.
• W3048404771 sameAs 3048404771 @default.
• W3048404771 citedByCount "4" @default.
• W3048404771 countsByYear W30484047712022 @default.
• W3048404771 countsByYear W30484047712023 @default.
• W3048404771 crossrefType "journal-article" @default.
• W3048404771 hasAuthorship W3048404771A5004327096 @default.
• W3048404771 hasAuthorship W3048404771A5004731367 @default.
• W3048404771 hasAuthorship W3048404771A5029096082 @default.
• W3048404771 hasAuthorship W3048404771A5070691919 @default.
• W3048404771 hasConcept C126322002 @default.
• W3048404771 hasConcept C127413603 @default.
• W3048404771 hasConcept C164705383 @default.
• W3048404771 hasConcept C168563851 @default.
• W3048404771 hasConcept C203092338 @default.
• W3048404771 hasConcept C2777628954 @default.
• W3048404771 hasConcept C2777849778 @default.
• W3048404771 hasConcept C2779134260 @default.
• W3048404771 hasConcept C2780007028 @default.
• W3048404771 hasConcept C2780645631 @default.
• W3048404771 hasConcept C3020199598 @default.
• W3048404771 hasConcept C541997718 @default.
• W3048404771 hasConcept C71924100 @default.
• W3048404771 hasConcept C78519656 @default.
• W3048404771 hasConceptScore W3048404771C126322002 @default.
• W3048404771 hasConceptScore W3048404771C127413603 @default.
• W3048404771 hasConceptScore W3048404771C164705383 @default.
• W3048404771 hasConceptScore W3048404771C168563851 @default.
• W3048404771 hasConceptScore W3048404771C203092338 @default.
• W3048404771 hasConceptScore W3048404771C2777628954 @default.
• W3048404771 hasConceptScore W3048404771C2777849778 @default.
• W3048404771 hasConceptScore W3048404771C2779134260 @default.
• W3048404771 hasConceptScore W3048404771C2780007028 @default.
• W3048404771 hasConceptScore W3048404771C2780645631 @default.
• W3048404771 hasConceptScore W3048404771C3020199598 @default.
• W3048404771 hasConceptScore W3048404771C541997718 @default.
• W3048404771 hasConceptScore W3048404771C71924100 @default.
• W3048404771 hasConceptScore W3048404771C78519656 @default.
• W3048404771 hasIssue "11" @default.
• W3048404771 hasLocation W30484047711 @default.
• W3048404771 hasLocation W30484047712 @default.
• W3048404771 hasOpenAccess W3048404771 @default.
• W3048404771 hasPrimaryLocation W30484047711 @default.
• W3048404771 hasRelatedWork W1584895772 @default.
• W3048404771 hasRelatedWork W1970967952 @default.
• W3048404771 hasRelatedWork W2022886132 @default.
• W3048404771 hasRelatedWork W2047171142 @default.
• W3048404771 hasRelatedWork W2073075672 @default.
• W3048404771 hasRelatedWork W2081658282 @default.
• W3048404771 hasRelatedWork W2157284846 @default.
• W3048404771 hasRelatedWork W2741762255 @default.
• W3048404771 hasRelatedWork W2926542596 @default.
• W3048404771 hasRelatedWork W3000604433 @default.
• W3048404771 hasVolume "29" @default.

• next